Improvement Seen in Survival With Adjuvant Pembrolizumab in Kidney Cancer

THURSDAY, April 18, 2024 -- For patients with clear-cell renal cell carcinoma, adjuvant pembrolizumab is associated with a significant and clinically meaningful improvement in overall survival, according to a study published in the April 18 issue...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news